IASO208 Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IASO208 Injection, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: IASO208 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies [Phase 1]